Purpose Patients with haematological malignancies are more likely to die in hospital, and less likely to access palliative care than people with other cancers, though the reasons for this are not well understood. The purpose of our study was to explore haematology nurses' perspectives of their patients’ places of care and death. Method Qualitative description, based on thematic content analysis. Eight haematology nurses working in secondary and tertiary hospital settings were purposively selected and interviewed. Transcriptions were coded and analysed for themes using a mainly inductive, cross-comparative approach. Results Five inter-related factors were identified as contributing to the likelihood of patients’ receiving end of life care/dy...
The ‘cure culture’ present in a haematology oncology unit in Malta poses a challenge to end-of-life...
There is now extensive consumer research to indicate that patients with haematological malignancies ...
Abstract Background Haematological malignancies (leukaemias, lymphomas and myeloma) are complex canc...
Purpose: Patients with haematological malignancies are more likely to die in hospital, and less like...
Purpose: Patients with haematological malignancies are more likely to die in hospital, and less like...
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. ...
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. ...
Objectives Current UK health policy promotes enabling people to die in a place they choose, which fo...
Objectives Current UK health policy promotes enabling people to die in a place they choose, which fo...
Aims: To explore haematological nurses' experiences about the palliative care trajectories of patie...
Background: Haematological malignancies (leukaemias, lymphomas and myeloma) are complex cancers that...
BackgroundHaematological malignancies (leukaemias, lymphomas and myeloma) are complex cancers that a...
BackgroundHaematological malignancies (leukaemias, lymphomas and myeloma) are complex cancers that a...
BackgroundHaematological malignancies (leukaemias, lymphomas and myeloma) are complex cancers that a...
BackgroundHaematological malignancies (leukaemias, lymphomas and myeloma) are complex cancers that a...
The ‘cure culture’ present in a haematology oncology unit in Malta poses a challenge to end-of-life...
There is now extensive consumer research to indicate that patients with haematological malignancies ...
Abstract Background Haematological malignancies (leukaemias, lymphomas and myeloma) are complex canc...
Purpose: Patients with haematological malignancies are more likely to die in hospital, and less like...
Purpose: Patients with haematological malignancies are more likely to die in hospital, and less like...
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. ...
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. ...
Objectives Current UK health policy promotes enabling people to die in a place they choose, which fo...
Objectives Current UK health policy promotes enabling people to die in a place they choose, which fo...
Aims: To explore haematological nurses' experiences about the palliative care trajectories of patie...
Background: Haematological malignancies (leukaemias, lymphomas and myeloma) are complex cancers that...
BackgroundHaematological malignancies (leukaemias, lymphomas and myeloma) are complex cancers that a...
BackgroundHaematological malignancies (leukaemias, lymphomas and myeloma) are complex cancers that a...
BackgroundHaematological malignancies (leukaemias, lymphomas and myeloma) are complex cancers that a...
BackgroundHaematological malignancies (leukaemias, lymphomas and myeloma) are complex cancers that a...
The ‘cure culture’ present in a haematology oncology unit in Malta poses a challenge to end-of-life...
There is now extensive consumer research to indicate that patients with haematological malignancies ...
Abstract Background Haematological malignancies (leukaemias, lymphomas and myeloma) are complex canc...